David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Ezio Di Nucci
Jack Alan Reynolds
Learn more about PhilPapers
Health Care Analysis 12 (2):91-115 (2004)
This paper uses John Rawls' theory of justice to defend the patent system against charges that it has an unfair effect on access to medications, from the perspective of national and international justice. The paper argues that the patent system is fair in a national context because it respects intellectual property rights and it benefits the least advantaged members of society by providing incentives for inventors, investors, and entrepreneurs. The paper also argues that the patent system is fair in an international context, provided that developed nations take steps to help disease-stricken countries secure internal justice. Fairness in a national or international context also requires that the patent system should include emergency exceptions to deal with short-term inequities
|Keywords||pharmaceutical patents justice fairness John Rawls TRIPS agreement HIV/AIDS developing nations|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
No citations found.
Similar books and articles
Sigrid Sterckx (2005). Can Drug Patents Be Morally Justified? Science and Engineering Ethics 11 (1):81-92.
Darryl J. Murphy (2012). Are Intellectual Property Rights Compatible with Rawlsian Principles of Justice? Ethics and Information Technology 14 (2):109-121.
R. Stephen Crespi (2005). Ethico-Legal Issues in Biomedicine Patenting: A Patent Professional Viewpoint. Science and Engineering Ethics 11 (1):117-136.
Neethu Rajam, Uk's National Patent Strategies and the Features of its Patent Abuses: Some Scattered Thoughts.
Sigrid Sterckx (2004). A Critique of the Utilitarian Argument for the Patent System. Philosophy in the Contemporary World 11 (2):81-88.
Paul Oldham, Biodiversity and the Patent System : Towards International Indicators. Submission to the Executive Secretary of the Convention on Biological Diversity.
Alex Rosenberg (2004). On the Priority of Intellectual Property Rights, Especially in Biotechnology. Politics, Philosophy and Economics 3 (1):77-95.
Samantha Byrne, Paul Davey, Kirsti McFarlane, John O'Brien & Craig Templeton (2006). Patent Rights or Patent Wrongs? The Case of Patent Rights on AIDS Drugs. Business Ethics 15 (3):299–305.
Ramona Albin (2010). Patents, Innovation, and Privatization. Science and Engineering Ethics 16 (4):777-781.
Rebecca S. Eisenberg (2002). How Can You Patent Genes? American Journal of Bioethics 2 (3):3 – 11.
Added to index2010-08-24
Total downloads20 ( #185,208 of 1,796,166 )
Recent downloads (6 months)1 ( #468,527 of 1,796,166 )
How can I increase my downloads?